Although the role of PGD2 and related ligands requires further attention, remodeling of the tumor immune microenvironment by TNF-α and NF-κB regulating, particularly by reducing the inflammatory cell infiltration, is an intriguing mechanism for resistance to some new immunotherapies. Here, PTGDS is linked to neoplasm.